Squarepoint Ops LLC Eton Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.06 - $3.75 $23,984 - $29,392	-7,838 Reduced 15.97%	41,255 $135,000
Q1 2024 May 15, 2024	SELL	$3.48 - $5.03 $49,871 - $72,084	-14,331 Reduced 22.6%	49,093 $184,000
Q4 2023 Feb 14, 2024	BUY	$3.45 - $4.66 $170,398 - $230,162	49,391 Added 351.96%	63,424 $277,000
Q2 2023 Aug 14, 2023	BUY	$3.32 - $4.04 $46,589 - $56,693	14,033 New	14,033 $48,000
Q3 2020 Nov 16, 2020	SELL	$4.96 - $9.06 $164,304 - $300,121	-33,126 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.5 - $6.09 $115,941 - $201,737	33,126 New	33,126 $181,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $297M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.